Article

Patient survey explores attitudes on alternative glaucoma care model

Projections on ophthalmology workforce size in the future-as well as growth in patient demand for services-indicates a clear need for more efficient delivery of glaucoma care. Going on the assumption that a tele-ophthalmological approach offers a possible solution, researchers at Johns Hopkins University, Baltimore, undertook a survey to gauge patient acceptance.

 

Baltimore-Projections on ophthalmology workforce size in the future-as well as growth in patient demand for services-indicates a clear need for more efficient delivery of glaucoma care. Going on the assumption that a tele-ophthalmological approach offers a possible solution, researchers at Johns Hopkins University, Baltimore, undertook a survey to gauge patient acceptance.

In the alternative-care model, patients underwent their usual battery of diagnostic testing at a convenient location. Decisions about scheduling patient visits with the ophthalmologist were based on the clinician’s remote review of the test results.

Fifty-nine adult patients with glaucoma were included in the survey that was designed to capture perceptions on current care delivery and the proposed model. The results showed that 91% of the surveyed patients were satisfied with the existing frequency of their clinic visits, and that a slight majority (58%) would be in favor of the new model.

“We have the need for an alternative care model and the technology to carry out the tele-ophthalmological approach,” said Ravi Pandit, MPH, a fourth year medical student, Dana Center for Preventive Ophthalmology Wilmer Eye Hospital, Baltimore. “However, implementation will be a challenge if we are unable to engage patient cooperation.”

Analyses of the data collected showed no differences in mean age or distance traveled to the clinic when comparing patients favoring the new model and those opposed to it.

 

 

Factors that did appear to drive acceptance included the number of clinic visits per year (the odds of acceptance decreased with each additional visit) and whether patients believed the model would result in convenience advantages (shorter wait times for testing and avoiding unnecessary visits were associated with increased acceptance).

The findings from the survey, mr. Pandit said, provide useful information for planning a pilot investigation of the alternative care model. He noted that the inverse association between visit frequency and patient acceptance indicates that reassurance will be critical to patient acceptance.

“Patients who have more visits are probably the sickest and the ones who would benefit most from the alternative-care model as they would get more time with their ophthalmologist,” he said. “This information needs to be communicated to these patients.

“Then, if we transition into this model, we must ensure that the vulnerable segments of the patient population are not negatively affected,” he concluded.

 

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.